Gastrofit

INSTRUCTIONS FOR MEDICAL USE OF THE MEDICINAL PRODUCT GASTROFIT

Composition:

Active substances: 1 package (50 g) contains a mixture of medicinal plant raw materials: liquorice roots (Liquiritiae radix) 4 g, Japanese sophora fruits (Sophorae japonicae fructus) 4 g, marshmallow roots (Althaea radix) 3.5 g, nettle leaves (Urticae folium) 3.5 g, peppermint leaves (Menthae piperitae folium) 3.5 g, marigold flowers (Calendulae flos) 3.5 g, chamomile flowers (Matricariae flos) 3.5 g, sand everlasting flowers (Helichrysi arenarii flos) 3.5 g, rosehip fruits (Rosaepseudo-fructus) 3.5 g, calamus roots (Calamiradix) 3 g, elder flowers (Sambuci flos) 3 g, yarrow herb (Millefolii herba) 3 g, St. John's wort herb (Hyperici herba) 3 g, medicinal sage leaves (Salviae officinalis folium) 3 g, wormwood herb (Absinthii herba) 2.5 g.

Pharmaceutical form. Herbal mixture.

Main physicochemical properties: mixture of fragments of various shapes, greyish-green in color, with reddish, orange, yellow and white inclusions. Weak, pleasant odor.

Pharmacotherapeutic group.

Agents affecting the digestive system and metabolic processes.

ATC code A16A X.

Pharmacological Properties.

Pharmacodynamics.

GASTROFIT exhibits spasmolytic properties, stimulates reparative processes in the mucous membrane of the stomach and duodenum, regulates functions of the gastrointestinal tract, normalizes intestinal motility. It also has choleretic and carminative effects.

Clinical characteristics.

Indications. Chronic gastritis with preserved or reduced gastric acid secretion; functional dyspepsia; duodenitis; prevention of relapses and as part of complex treatment of gastric and duodenal ulcers, colitis.

Contraindications. Hypersensitivity to any component of the drug. Hypertensive disease grade II–III, acute and chronic heart failure, hypokalemia, obstructive jaundice, cholelithiasis with presence of stones over 10 mm in diameter, acute cholecystitis, acute hepatitis, liver cirrhosis, acute pancreatitis, lobar pneumonia, obstructive bronchitis, spasmophilia, thrombophlebitis, increased blood coagulation.

Special precautions. During treatment, exposure to intense UV radiation should be avoided.

Interaction with other medicinal products and other forms of interaction. With prolonged simultaneous use of cardiac glycosides, adrenocorticosteroids, antiarrhythmic agents (quinidine), laxatives, thiazide and loop diuretics, disturbance of water-electrolyte balance is possible.

Usage peculiarities.

Use during pregnancy or breastfeeding. The medicinal product is contraindicated during pregnancy. If it is necessary to use the medicinal product, breastfeeding should be discontinued.

Ability to affect reaction rate when driving or operating machinery. During the use of this medicinal product, patients should refrain from potentially hazardous activities requiring increased attention and psychomotor reaction speed (such as driving vehicles or operating complex machinery).

Dosage and Administration

Steep 2 tablespoons of the herbal mixture in 500 ml of boiling water. Let it stand, covered, for 1 hour, then strain.

For adults and children aged 12 years and older: take ⅔ cup (150 ml) of the warm preparation 20–30 minutes before meals, three times daily.

The duration of treatment is determined by a physician. On average, treatment course lasts from 1 to 2 months; if necessary, the course may be repeated.

Children. The product is contraindicated in children under 12 years of age.

Overdose. Possible intensification of adverse reactions, dyspeptic symptoms, edema, and increased arterial blood pressure.

Adverse reactions.

The medicinal product is generally well tolerated by patients. However, due to its multi-component composition, allergic reactions may occur, mostly in cases of individual hypersensitivity to any of the components or in case of violation of the recommended dosage regimen. Such reactions may include itching, rash, urticaria, dermatitis, skin swelling, and photosensitivity. In the event of any adverse reactions, it is necessary to consult a physician.

Shelf life. 2 years. Do not use after the expiry date stated on the packaging.

Storage conditions. In the original packaging, at a temperature not exceeding 25 °C, in a place inaccessible to children.

Packaging. 50 g in a sachet, placed in a carton.

Prescription status. Over-the-counter.

Manufacturer. LLC "Scientific and Production Pharmaceutical Company "EYM".

Manufacturer's location and address of business activity. 20 lit. A-5, Kharkivs'kykh Dyviziy St., Kharkiv, Kharkiv region, 61091, Ukraine.

INSTRUCTION

for medical use of the medicinal product

GASTROFIT

Composition:

Active substances: 1 package (100 g) contains a mixture of medicinal plant raw materials: licorice roots (Glycyrrhizae radix) 8 g, Japanese sophora fruits (Sophorae japonicae fructus) 8 g, marshmallow roots (Althaeae radix) 7 g, nettle leaves (Urticae folium) 7 g, peppermint leaves (Menthae piperitae folium) 7 g, marigold flowers (Calendulae flos) 7 g, chamomile flowers (Matricariae flos) 7 g, sand everlasting flowers (Helichrysi arenarii flos) 7 g, rosehip fruits (Rosae pseudo-fructus) 7 g, calamus roots (Calami radix) 6 g, elder flowers (Sambuci flos) 6 g, yarrow herb (Millefolii herba) 6 g, St. John's wort herb (Hyperici herba) 6 g, sage leaves (Salviae officinalis folium) 6 g, wormwood herb (Absinthii herba) 5 g.

Pharmaceutical form. Herbal mixture.

Main physico-chemical properties: a mixture of irregularly shaped fragments of greyish-green color with reddish, orange, yellow, and white inclusions. Odor is weak, pleasant.

Pharmacotherapeutic group.

Agents affecting the digestive system and metabolic processes.

ATC code A16A X.

Pharmacological properties.

Pharmacodynamics.

GASTROFIT exhibits spasmolytic properties, stimulates reparative processes in the mucous membrane of the stomach and duodenum, regulates gastrointestinal tract functions, normalizes intestinal motility. It also has choleretic and carminative effects.

Clinical characteristics.

Indications. Chronic gastritis with preserved or reduced gastric acid secretion; functional dyspepsia; duodenitis; prevention of relapses and as part of complex treatment of gastric and duodenal ulcer disease, colitis.

Contraindications. Hypersensitivity to any component of the drug. Hypertensive disease grade II–III, acute and chronic heart failure, hypokalemia, obstructive jaundice, cholelithiasis with presence of stones over 10 mm in diameter, acute cholecystitis, acute hepatitis, liver cirrhosis, acute pancreatitis, lobar pneumonia, obstructive bronchitis, spasmophilia, thrombophlebitis, increased blood coagulability.

Special precautions. During treatment, exposure to intense UV radiation should be avoided.

Interaction with other medicinal products and other forms of interaction. With prolonged simultaneous use with cardiac glycosides, adrenocorticosteroids, antiarrhythmic agents (quinidine), laxatives, thiazide and loop diuretics, disturbances in water-electrolyte balance are possible.

Instructions for use.

Use during pregnancy or breastfeeding. The medicinal product is contraindicated during pregnancy. If it is necessary to use the drug, breastfeeding should be discontinued.

Ability to affect reaction rate when driving or operating machinery. During the use of the medicinal product, it is recommended to avoid potentially hazardous activities requiring heightened attention and psychomotor speed (driving vehicles and operating complex machinery).

Dosage and Administration.

Steep 2 tablespoons of the mixture in 500 ml of boiling water, let stand in a closed container for 1 hour, then strain.

For adults and children aged 12 years and older, take ⅔ cup (150 ml) warm, 20–30 minutes before meals, three times daily.

The duration of use should be determined by a physician. On average, the treatment course lasts from 1 to 2 months; if necessary, the course may be repeated.

Children. The drug is contraindicated in children under 12 years of age.

Overdose. May result in intensified adverse reactions, dyspeptic symptoms, edema, and increased arterial blood pressure.

Side effects.

The medicinal product is generally well tolerated by patients. However, due to its multi-component composition, allergic reactions may occur, mostly in cases of individual hypersensitivity to any of the components or in violation of the recommended dosage regimen. Such reactions may include itching, rash, urticaria, dermatitis, skin swelling, and photosensitivity. In case of any adverse reactions, consult a physician.

Shelf life. 2 years. Do not use after the expiry date stated on the package.

Storage conditions. Store in the original packaging at a temperature not exceeding 25 °C, in a place inaccessible to children.

Packaging. 100 g per packet, placed in a carton.

Availability. Over-the-counter (without prescription).

Manufacturer. LLC "Scientific and Production Pharmaceutical Company "EYM".

Manufacturer's address. 20 Lityera "A-5", Kharkivs'kykh Dyviziya St., Kharkiv, Kharkiv region, 61091, Ukraine.

INSTRUCTION

for medical use of the medicinal product

GASTROFIT

Composition:

Active substances: 1 filter bag (1.5 g) contains a mixture of herbal raw materials: Liquorice roots (Liquiritiae radix) 120 mg, Japanese pagoda tree fruits (Sophorae japonicae fructus) 120 mg, Marshmallow roots (Althaeae radix) 105 mg, Nettle leaves (Urticae folium) 105 mg, Peppermint leaves (Menthae piperitae folium) 105 mg, Marigold flowers (Calendulae flos) 105 mg, Chamomile flowers (Matricariae flos) 105 mg, Sand everlasting flowers (Helichrysi arenarii flos) 105 mg, Rosehip fruits (Rosae pseudo-fructus) 105 mg, Sweet flag rhizome (Calami radix) 90 mg, Elder flowers (Sambuci flos) 90 mg, Yarrow herb (Millefolii herba) 90 mg, St. John's wort herb (Hyperici herba) 90 mg, Sage leaves (Salviae officinalis folium) 90 mg, Wormwood herb (Absinthii herba) 75 mg.

Pharmaceutical form. Herbal mixture.

Main physico-chemical properties: a mixture of fragments of various shapes, grayish-green in color, with reddish-brown, orange, yellow, and white inclusions. Odor is weak, pleasant.

Pharmacotherapeutic group.

Agents affecting the digestive system and metabolic processes.

ATC code A16A X.

Pharmacological properties.

Pharmacodynamics.

GASTROFIT exhibits spasmolytic properties, stimulates reparative processes in the mucous membrane of the stomach and duodenum, regulates gastrointestinal tract functions, normalizes intestinal motility. It also has choleretic and carminative effects.

Clinical characteristics.

Indications. Chronic gastritis with preserved or reduced gastric acid secretion; functional dyspepsia; duodenitis; prevention of relapses and as part of complex treatment of gastric and duodenal ulcer disease, colitis.

Contraindications. Hypersensitivity to any component of the drug. Hypertensive disease grade II–III, acute and chronic heart failure, hypokalemia, obstructive jaundice, cholelithiasis with presence of stones over 10 mm in diameter, acute cholecystitis, acute hepatitis, liver cirrhosis, acute pancreatitis, lobar pneumonia, obstructive bronchitis, spasmophilia, thrombophlebitis, increased blood coagulation.

Special precautions. During treatment, exposure to intense UV radiation should be avoided.

Interaction with other medicinal products and other forms of interaction. With prolonged simultaneous use of cardiac glycosides, adrenocorticosteroids, antiarrhythmic agents (quinidine), laxatives, thiazide and loop diuretics, disturbance of water-electrolyte balance is possible.

Special precautions.

Use during pregnancy or breastfeeding. The medicinal product is contraindicated during pregnancy. If it is necessary to use the drug, breastfeeding should be discontinued.

Ability to affect reaction speed when driving or operating machinery. During the use of the medicinal product, potentially hazardous activities requiring heightened attention and increased psychomotor reaction speed (such as driving vehicles or operating complex machinery) should be avoided.

Method of Administration and Dosage.

Pour 150 ml of boiling water over 2 filter bags and let steep in a closed container for 15 minutes.

For adults and children aged 12 years and older, take 150 ml of the warm preparation 20–30 minutes before meals three times daily.

The duration of use should be determined by a physician. On average, the treatment course lasts from 1 to 2 months; if necessary, the course may be repeated.

Children. The drug is contraindicated for children under 12 years of age.

Overdose. May result in increased severity of adverse reactions, dyspeptic symptoms, edema, and elevated arterial pressure.

Adverse reactions.

The medicinal product is generally well tolerated by patients. However, due to its multi-component composition, allergic reactions may occur, mostly in cases of individual hypersensitivity to any of the components or in case of improper use. Possible reactions include skin itching, rash, urticaria, dermatitis, skin swelling, and photosensitivity. In case of any adverse reactions, consult a physician immediately.

Shelf life. 2 years. Do not use after the expiry date stated on the packaging.

Storage conditions. Store in the original packaging at a temperature not exceeding 25 °C, in a place inaccessible to children.

Packaging. 1.5 g in a filter bag, 20 bags per pack.

Supply classification. Over-the-counter.

Manufacturer. LLC "Scientific and Production Pharmaceutical Company "EYM".

Manufacturer's address. 20 lit. "A-5", Kharkivs'kykh Dyviziï Street, Kharkiv, Kharkiv region, 61091, Ukraine.